Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.
Dr Kenneth Tsang, Regional CEO of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong ...
A person can seem healthy and still carry subtle biological signs of trouble long before the first tremor or slowed movement ...
Millions of Americans are turning to AI chatbots for health answers. But are doctors using these tools? And if so, how?
Dr. Mitch Rosner is the CEO of U.Va. Health and Executive Vice President of Health Affairs at the University. He can be ...
The placebo effect is more than just mental – it’s a biological system that can measurably improve a patient’s symptoms. But ...
That’s a gigantic number for a health condition that has felt pretty hopeless in the past. The initial research into ...
The life and legacy of national icon Dr Mavis Gilmour-Petersen stand as a powerful testament to purpose, perseverance, and an ...
UAB neurologists are expanding global health efforts in Kenya by providing neurological care and medical training in Kijabe, ...
As physicians navigate the subsidy expirations and new efficiency mandates, which specialties do doctors feel are most and ...
A clinical trial in Oklahoma testing the drug Prasinezumab is offering new hope for people with Parkinson’s disease by aiming ...